Search for: "Kevin Noonan"
Results 1021 - 1040
of 1,063
Sorted by Relevance
|
Sort by Date
22 Feb 2012, 9:00 pm
The authors, Donald Zuhn and Kevin Noonan, are partners at McDonnell Boehnen Hulbert & Berghoff, LLP, and contribute to Patent Docs on a daily basis. [read post]
28 Nov 2012, 7:06 am
Twitter: @IPWatchdog PATENT DOCS We agree with Gene Quinn over at IPWatchdog that Kevin Noonan, Donald Zuhn—both partners at Chicago’s McDonnell Boehnen Hulbert & Berghoff—and their team of contributors at Patent Docs are overdue for recognition in the IP category here. [read post]
1 Jun 2009, 2:46 pm
Noonan of McDonnell Boehnen Hulbert & Berghoff LLP (and Patent Docs). [read post]
24 Apr 2012, 10:00 pm
The authors, Donald Zuhn and Kevin Noonan, are partners at McDonnell Boehnen Hulbert & Berghoff, LLP, and contribute to Patent Docs on a daily basis. [read post]
22 Feb 2012, 9:00 pm
The authors, Donald Zuhn and Kevin Noonan, are partners at McDonnell Boehnen Hulbert & Berghoff, LLP, and contribute to Patent Docs on a daily basis. [read post]
24 Jun 2020, 8:52 am
[BiogenCAFCDecision] [Discussion by Kevin Noonan] [Biogen en banc petition] [Biogen PhRMA Amicus] = = = = = Dragon Intellectual Property v. [read post]
29 Oct 2010, 11:01 pm
The IPO brief was written by Paul Berghoff, Kevin Noonan, and their team at the MBHB law firm. [read post]
1 Jun 2007, 8:13 am
Noonan at Patent Docs regarding McKesson v. [read post]
29 Mar 2011, 11:35 am
Senior Chief Petty Officer Kevin M. [read post]
28 Mar 2012, 10:00 pm
The authors, Donald Zuhn and Kevin Noonan, are partners at McDonnell Boehnen Hulbert & Berghoff, LLP, and contribute to Patent Docs on a daily basis. [read post]
17 Jun 2012, 3:52 pm
Patent Docs, Kevin Noonan & Don Zuhn Kevin Noonan has extensive experience in biotechnology and the chemical arts. [read post]
19 Apr 2013, 6:54 am
At Patent Docs, Kevin Noonan comments on Monday’s oral argument in Association for Molecular Pathology v. [read post]
26 Mar 2010, 8:21 am
Of citation to something in SSRN, one contemplates the "gray literature" debate in ClimateGate.]Kevin Noonan had a detailed post, but did not mention all those law reviews written in favor of what turned out to be a losing (9-2) proposition. [read post]
21 Jul 2017, 8:33 am
No expert testified that they foresaw, or expected, or would have intended, the reaction between bortezomib and mannitol, or that the resulting ester would have the long-sought properties and advantages.Separately, Kevin Noonan wrote: The opinion suggests that obviousness requires the art to provide a reason for taking the particular experimental route leading to the claimed success, as well as a reasonable expectation of achieving that success. [read post]
20 Jan 2015, 4:30 am
”Moreover, the court did not state the obvious, that Ariosa could have been fit within the contours of the Mayo decision, as Kevin Noonan has explained. [read post]
2 Apr 2019, 3:46 pm
I'll discuss a scholarly work-in-progress with Janet Freilich, and I've also been invited to serve on a panel on "Roles and Influence of Patent Blogs" (with Kevin Noonan from Patent Docs and Jason Rantanen from Patently-O, and Written Description's own Camilla Hrdy serving as moderator). [read post]
23 Nov 2006, 5:35 pm
Kevin Noonan). [read post]
12 Oct 2017, 8:29 am
” Seven Chicago Attorneys: A group led by Kevin Noonan argue that the district court “violated procedural due process” by failing to provide an opportunity to be heard on the question of specific intent to deceive the USPTO — noting that due process concerns are raised when dealing with lawyer misconduct accusations. [read post]
30 Aug 2011, 10:07 pm
Notes from around the patently-o-sphere: Kevin Noonan writes that “the decision provides a contrast between how the Court views chemical obviousness for pharmaceutical formulations today, and the views contained in the Court's opinion in Pfizer, Inc. v. [read post]
22 Jan 2024, 1:16 pm
(Amicus Curiae): Douglas Hallward-Driemeier – Ropes & Gray LLP Amici: USPTO: Kakoli Caprihan (Solicitors Office) Pharmaceutical Research and Manufacturers of America (Amicus Curiae): Jeffrey Kushan – Sidley Austin LLP Intellectual Property Owners Association (Amicus Curiae):Paul Berghoff – McDonnell Boehnen Hulbert & Berghoff LLP Biotechnology Innovation Organization (Amicus Curiae): Kevin Edward Noonan – McDonnell Boehnen Hulbert & Berghoff… [read post]
